The pathological association between down syndrome and Alzheimer disease

Mechanisms of Ageing and Development

Volumn 43, Issue 2, 1988, Pages 99-136

  Mann, David M A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer disease; Down syndrome; Pathogenesis

Indexed keywords

ADULT; AGE; AGING; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; DOWN SYNDROME; EPIDEMIOLOGY; HISTOLOGY; HUMAN; HUMAN CELL; METHODOLOGY; NEUROFILAMENT; REVIEW; SENILE PLAQUE;

AGE FACTORS; ALZHEIMER DISEASE; ATROPHY; BRAIN; COMPARATIVE STUDY; DOWN SYNDROME; FEMALE; HUMAN; MALE;

EID: 0023889961     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/0047-6374(88)90041-3     Document Type: Article

References (129)

1. Down's syndrome
2. Human chromosome abnormalities as related to physical and mental dysfunction
3. Mortality and life expectancy of Down's syndrome in Denmark
4. Life expectancy in Down's syndrome
5. Kalmuc idiocy: report of a case with autopsy with notes on 62 cases
6. Histopathologische Untersuchungen uber Entstehung und Wesen der senilen plaques
7. Early senile dementia and mongoloid idiocy
8. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes
9. Relationship between pigment accumulation and age in Alzheimer's disease and Down's syndrome
10. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age
11. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age
12. The topography of plaques and tangles in Down's syndrome patients of different ages
13. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age
14. Brain weight in the adult mongol
15. Demonstration of neurofibrillary tangles in paraffin section — a quick and simple method using Palmgrens technique
16. A method for the in situ estimation of RNA using Azure B
17. Cas d'idiotie mongolienne adult avec nombreuses plaques seniles et concretions calcaires pallidales
18. Alzheimer's disease and senile dementia as seen in mongoloids: neuropathological observations
19. Langdon Down syndrome and Alzheimer's disease
20. Alzheimer's disease in Down's syndrome: clinical and neuropathological observations
21. Presenile dementia and Alzheimer's disease in mongolism
22. Electronmicroscopical study of the brain in Down's syndrome
23. The development of the pathological changes of Alzheimer's disease and senile dementia in patients with Down's syndrome
24. Neurofibrillary tangles in patients with Down's syndrome: A light and electron microscopic study
25. Presenile dementia in Down's syndrome
26. Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly mongol
27. Alzheimer degeneration in Down's syndrome
28. The incidence of ultrastructural abnormalities in the cortex of two retarded human brains (Down's syndrome)
29. Reply to W. Hughes
30. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia
31. Neurofibrillary tangles and granulovacuolar degeneration and neurone loss in Down's syndrome: quantitative comparison with Alzheimer dementia
32. Relationship between plaques and tangles and dementia in Down's syndrome
33. Myoclonus in Down's syndrome
34. Morphological features of Pick's and atypical Alzheimer's disease in Down's syndrome
35. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease
36. Catecholamines and cholinergic enzymes in presenile and senile Alzheimer type dementia and Down's syndrome
37. The hippocampus in Down's syndrome
38. Down's syndrome: is there a decreased population of neurones
39. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
40. Alzheimer's disease in Down's syndrome
41. Re-examination of the pathogenesis of the senile plaque
42. Isolated senile plaques cores in Alzheimer's disease and Down's syndrome show differences in morphology
43. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome
44. The isolation and amino acid composition of senile plaque core protein
45. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
46. Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease
47. Neuritic plaques and cerebrovascular amyloid in Alzheimer's disease are antigenically related
48. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril
49. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels
50. Aluminosilicates and the ageing brain: implication for the pathogenesis of Alzheimer's disease
51. Neurofibrillary tangles of Alzheimer's disease show antigenic determinants with the axonal microtubule associated protein tau (τ)
52. Microtubule associated protein tau (τ) is a major antigenic determinant of PHF in Alzheimer's disease
53. Abnormal phosphorylation of the microtubule associated protein tau (τ) in Alzheimer's skeletal pathology
54. Phosphorylated tau protein is integrated into PHF in Alzheimer's disease
55. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants
56. A quantitative study of cerebral atrophy in old age and senile dementia
57. The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations
58. Transmitter deficits in Alzheimer's disease
59. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders
60. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease
61. Alzheimer's disease and Down's syndrome
62. Abnormalities of the nucleus basalis in Down's syndrome
63. Alzheimer-like cholinergic deficiency in Down's syndrome
64. Neurotensin immunoreactivity is increased in Down's syndrome but not in Alzheimer type dementia
65. Noradrenaline in Alzheimer type dementia and Down's syndrome
66. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue
67. Regional brain 5 hyroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease
68. The anterior commissure in Down's syndrome
69. The brain in mongolian idiocy
70. The structure of the cerebral cortex in Down's syndrome
71. Morphometric studies of neurones in the visual cortex of Down's syndrome brains
72. Pathology of the auditory system in trisomies with morphometric and quantitative study of the ventral cochlear nucleus
73. Acetylcholine and aromatic amine systems in post mortem brain of an infant with Down's synrome
74. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome
75. Spine distribution along the apical dendrite of the pyramidal neurones in Down's syndrome
76. Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome
77. Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down's syndrome
78. A quantitative study of lipofuscin accumulation with age in normals and individuals with Down's syndrome, phenylketonuria, progeria and transneuronal atrophy
79. Basal ganglia calcification (BGC) in Down's syndrome (DS) — Another manifestation of premature ageing
80. Basal ganglia calcification in Down's syndrome
81. Bilateral basal ganglia calcification visualized on CT scan
82. The significance of the incidental finding of basal ganglia calcification in computed tomography
83. The incidence, composition and pathological significance of intracerebral vascular deposits in the basal ganglia
84. Presenile sclerosis (Alzheimer's disease) with features resembling Pick's disease
85. A case of combined Pick's disease and Alzheimer's disease
86. Pick body like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease
87. Idiopathic Parkinson's disease and the Lewy body disorders
88. Developmental and other pathologic changes in syndromes caused by chromosome abnormalities
89. Down's syndrome: Its frequency in human populations and some factors pertinent to variations in rates
90. Genetic factors in Down's syndrome and their possible role in the pathogenesis of Alzheimer's disease
91. Alzheimer's disease in Down's syndrome
92. Alzheimer's disease in Down's syndrome: visual retention deficits
93. Precocious ageing and dementia in patients with Down's syndrome
94. Dementia in Down's syndrome: observations from a neurology clinic
95. Development of Alzheimer's disease in Down's syndrome individuals
96. Age related neuropsychological deficits in Down's syndrome
97. Ageing in Down's syndrome
98. Down's syndrome and Alzheimer's disease: a review
99. Alzheimer's disease: cell specific pathology isolates the hippocampal formation
100. The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages
101. Senile changes in the brain in the Japanese: incidences of Alzheimer's neurofibrillary changes and senile plaques
102. Alzheimer changes in non-demented patients younger than 65: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type
103. The variable topography of Alzheimer type changes in senile dementia and normal old age
104. A new definition of Alzheimer's disease: a hippocampal dementia
105. On areas of transition between entorhinal allocortex and temporal isocortex in human brain
106. The olfactory bulbs in Alzheimer's disease
107. Alzheimer's disease: an olfactory connection?
108. Viruses, Parkinsonism and Alzheimer's disease
109. Neurological disease and Herpes Simplex virus
110. Viruses and Alzheimer's disease
111. Herpes Simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridization
112. Search for viral DNA sequences in Alzheimer brain tissue
113. Herpes simplex virus: a role in the aetiology of Alzheimer's disease?
114. Metabolism of oxygen derivatives in Down's syndrome
115. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brains
116. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type
117. Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer's disease and other dementias
118. The genetic defect causing familial Alzheimer's disease maps on chromosome 21
119. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
120. Chromosome 21 q 21 sublocalization of gene encoding Beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzeheimer's disease and Down's syndrome
121. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
122. Amyloid B protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus
123. Failure of familial Alzheimer's disease to segregate with the A4 amyloid gene in several European families
124. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid protein gene
125. Atypical Down's syndrome and partial trisomy 21